BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230418
DTEND;VALUE=DATE:20230421
DTSTAMP:20260516T055812
CREATED:20230119T091650Z
LAST-MODIFIED:20230119T091650Z
UID:36291-1681776000-1682035199@www.pharmajournalist.com
SUMMARY:3rd Fc Receptor Pathway Targeted Therapies 2023
DESCRIPTION:The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx\, Janssen\, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune diseases as the next big drug opportunity. \nThe 3rd Fc Receptor Pathway Targeted Therapies Summit will once again feature unmissable conversations to advance targeting FcR and the subsequent generation of Fc manipulation since real-world proof and clinical value are now at the industry’s fingertips. \nJoin 100+ of your colleagues at the 3rd Fc Receptor Pathway Targeted Therapies Summit – from the fields of immunology\, antibody engineering\, pharmacology\, toxicology\, and immuno-oncology for three days of content that is unmatched in its scope\, all focused on the optimization of FcRn\, FcγR\, and novel Fc. \nPut your stake in the ground to revolutionise autoimmune illness and position yourself in front of the next wave of blockbuster drug development. \nTo know more visit: https://ter.li/y9vxt6
URL:https://www.pharmajournalist.com/event/3rd-fc-receptor-pathway-targeted-therapies-2023/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230418
DTEND;VALUE=DATE:20230421
DTSTAMP:20260516T055812
CREATED:20230127T095023Z
LAST-MODIFIED:20230127T095023Z
UID:36387-1681776000-1682035199@www.pharmajournalist.com
SUMMARY:mRNA Process Development & Manufacturing Europe
DESCRIPTION:mRNA therapeutics have catapulted into the limelight amidst the COVID-19 pandemic with multiple EMA approvals to help combat the virus. \nBringing together KOLs sharing case studies with actionable insights\, the inaugural mRNA Process Development & Manufacturing Summit Europe has been established as the first forum in Europe to support your in-house process development and manufacturing strategies. \nThe 3-day agenda has been carefully co-authored along with the leaders within the industry from the likes of BioNTech\, AstraZeneca and Genentech. A snapshot of key topics include: \n\nAssessing how dsRNA formation can be limited to reduce the purification requirements of the manufacturing process with BioNTech SE\nUncovering how to maximise biocomparability when scaling up the batch manufacturing process\, including identifying the critical process steps that introduce batch-to-batch variability with Genentech & Roche\nA snapshot of robust\, high-throughput online novel assays for identifying impurities with CureVac & AstraZeneca\nUnderstanding critical quality attributes and the differences in process development considerations for mRNA therapeutics and vaccines to achieve appropriate drug substance quality with the University of Sheffield & University Hospital Zurich\nHearing how the global market could function with a standard process platform to benefit all patients with Medicines Patent Pool\n\nThis is an opportunity to join 80+ mRNA enthusiasts from mRNA manufacturing\, analytics\, process development\, CMC\, quality control\, and drug substance to get key insights on scaling up mRNA drug substances in Europe whilst navigating mRNA process development and manufacturing regulatory guidelines to create commercially successful mRNA vaccines and therapeutics. \nTo know more visit: https://ter.li/f3ec38
URL:https://www.pharmajournalist.com/event/mrna-process-development-manufacturing-europe/
LOCATION:Sheraton Offenbach Hotel\, Am Buesing Palais\, Berliner Str. 111\,\, Offenbach am Main\, 63065\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR